Therapies
Saturday, July 21st, 2012
Stroke.ahajournals.org: July 17, 2012. There are few validated models for prediction of risk of symptomatic intracranial hemorrhage (sICH) after intravenous tissue-type plasminogen activator treatment for ischemic stroke. We used data from Get With The Guidelines–Stroke (GWTG-Stroke) to derive and validate a prediction tool for determining sICH risk. Methods—The population consisted of 10 242 patients from 988 […]
Therapies
Saturday, July 21st, 2012
Onlinelibrary.wiley.com: July 16, 2012. Stroke motor rehabilitation is typically generic rather than being tailored to the individual and yet individuals may require different rehabilitation strategies according to the brain regions and networks damaged by the stroke and the impact of the lesion on remote locations and networks. Training may be targeted at facilitating neuroplasticity of these […]
Therapies
Saturday, July 21st, 2012
Stroke.ahajournals.org: July 12, 2012. Few studies have addressed outcomes among patients ≥80 years treated with acute stroke therapy. In this study, we outline in-hospital outcomes in (1) patients ≥80 years compared with their younger counterparts; and (2) those over >80 years receiving intra-arterial therapy (IAT) compared with those treated with intravenous recombinant tissue-type plasminogen activator (IV […]
Atrial Fibrillation
Saturday, July 21st, 2012
Atrialfibrillationblog.com: July 17, 2012. The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for […]
Atrial Fibrillation
Saturday, July 21st, 2012
Onlinelibrary.wiley.com: Article first published online: 16 JUL 2012 Stroke associated with atrial fibrillation may occur in up to one third of people who experience an ischemic event, and results in greater stroke severity and poorer health outcomes. The ageing population in developed and developing countries will lead to an increase in the prevalence of atrial fibrillation […]
Atrial Fibrillation
Saturday, July 21st, 2012
Sciencedirect.com: July 13, 2012. Atrial fibrillation guidelines recommend long-term use of warfarin according to a patient’s predicted risk of stroke. After acute myocardial infarction, however, combining warfarin and antiplatelet medications poses challenges. Methods By using data from more than 69,255 patients with acute myocardial infarction who were enrolled in the National Cardiovascular Data Registry’s Acute […]
Atrial Fibrillation
Saturday, July 21st, 2012
Eeurheartj.oxfordjournals.org: July 2, 2012. Aims The availability of new antithrombotic agents, each with a unique efficacy and bleeding profile, has introduced a considerable amount of clinical uncertainty with physicians. We have developed a clinical decision aid in order to assist clinicians in determining an optimal antithrombotic regime for the prevention of stroke in patients who are […]
Atrial Fibrillation
Saturday, July 21st, 2012
Ahdbonline.com: Wayne Kuznar, June 1, 2012. Chicago, IL—“Difficult” atrial fibrillation (AF), for which standard ratecontrol therapy or standard rhythmcontrol therapy has not been effective, or AF in the setting of sinus node or other conduction disease, has been shown to sometimes benefit from nonstandard or combination-drug treatment, according to James A. Reiffel, MD, Professor of Clinical […]
Guidelines
Saturday, July 21st, 2012
Atrialfibrillationblog.com: JULY 19, 2012 AT 9:00 AM. The Atrial Fibrillation Optimal Treatment Task Force, led by the Alliance for Aging Research, has just released a consensus statement developed by a group of leading afib stroke prevention experts. We at StopAfib.org are proud to have been part of the development of this consensus statement, which recommends a process for […]
Atrial Fibrillation
Thursday, July 12th, 2012
American Heart Association: Background—There is a paucity of international data on the various types of atrial fibrillation (AF) outside of the highly-selected populations from randomized trials. This study aimed to describe patient characteristics, risk factors, comorbidities, symptoms, management strategy, and control of different types of AF in real-life practice. Methods and Results—RealiseAF was a contemporary, […]
